BIOMAT Database Logo BIOMAT Database Logo

Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients. 1981

N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D003619 Dansyl Compounds Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group. Dimethylaminonaphthalenesulfonyl Compounds,Compounds, Dansyl,Compounds, Dimethylaminonaphthalenesulfonyl
D005260 Female Females
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II.
August 1979, Biochemical and biophysical research communications,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins.
August 1974, The Journal of biological chemistry,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing.
November 1978, Journal of lipid research,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Immunochemistry of human very low density lipoproteins: apolipoprotein C-III.
January 1980, Biochemistry,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
[THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
December 2015, Klinicheskaia laboratornaia diagnostika,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis.
March 1988, Journal of lipid research,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Apolipoprotein A-II can incorporate into plasma very low density lipoproteins.
September 1981, FEBS letters,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
August 2006, Metabolism: clinical and experimental,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis.
January 1976, Biochimica et biophysica acta,
N Matsuoka, and K Shirai, and J D Johnson, and M L Kashyap, and L S Srivastava, and T Yamamura, and A Yamamoto, and Y Saito, and A Kumagai, and R L Jackson
Purification of apolipoproteins C-II and C-III from human very low density lipoproteins.
January 1986, Acta cientifica venezolana,
Copied contents to your clipboard!